Table-I.
25(OH)D Levels (ng/ml) |
AML
|
ALL
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A1 | B1 | A2 | B2 | |||||||||
n (%) | Mean 25(OH)D Levels (ng/ml) |
p * | n (%) | Mean 25(OH)D Levels (ng/ml) | p * | n (%) | Mean 25(OH)D Levels (ng/ml) |
p* | n (%) | Mean 25(OH)D Levels (ng/ml) |
p* | |
Total | 17 | 13 | 31 | 25 | ||||||||
<10 | 5 (5.8) | 13.7 (±5.6) | 0.21 | 3 (3.5) |
16.2 (±9.0) | 0.66 | 8 (9.3) | 30.2 (±10.2) | 0.67 | 11 (12.8) | 14.4 (±5.7) | 0.28 |
10-29 | 10 (11.6) | 16.2 (±6.1) | 10 (11.6) | 14.3 (±5.7) | 21 (24.4) | 15.7 (±9.4) | 14 (16.3) | 27.5 (±19.3) | ||||
30-100 | 2 (2.3) | 26.3 (±21.7) | - | - | 1 (1.2) | 19.4 (±3.0) | - | |||||
>100 | - | - | - | - | 1 (1.2) | - | - |
Table shows the differences between groups of acute leukemia according to vitamin D [25(OH)D] levels, defined as <10 ng/ml: Deficient levels, 10-29: Insufficient levels, 30-100: Normal levels, >100: High normal levels. All quantitative variables are expressed as mean±SD. N shows number of participants. Vitamin D3 insufficiency is represented in par enthesis as percentage. Level of significance was p<0.05.